Immix Biopharma (IMMX) Operating Leases (2024 - 2026)

Immix Biopharma (IMMX) reported Operating Leases of $912343.0 for Q1 2026, down 7.95% on a YoY basis from $991126.0 in Q1 2025, and down 2.28% sequentially from $933625.0 in Q4 2025.

Immix Biopharma (IMMX) Operating Leases (2024 - 2026) Analysis & Trends

Immix Biopharma (IMMX) has 3 years of Operating Leases data on file, last reported at $912343.0 in Q1 2026.

  • For the quarter ending Q1 2026, Operating Leases fell 7.95% year-over-year to $912343.0; the trailing twelve-month figure through Mar 2026 stood at $912343.0 (down 7.95% YoY), and the FY2025 full-year result was $933625.0, down 7.52% from the prior year.
  • Operating Leases fell to $912343.0 in Q1 2026, from $933625.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $1.1 million in Q1 2024 to a low of $912343.0 in Q1 2026.
  • A 3-year average of $990235.6 and a median of $991126.0 in 2025 frame the typical range for Operating Leases.
  • Across the five-year window, Operating Leases decreased 5.97% in 2025 and retreated 7.95% in 2026, its largest moves.
  • Tracing IMMX's Operating Leases over 3 years: stood at $1.0 million in 2024, then retreated by 7.52% to $933625.0 in 2025, then fell by 2.28% to $912343.0 in 2026.
  • Business Quant data shows IMMX's Operating Leases at $912343.0 in Q1 2026, $933625.0 in Q4 2025, and $965053.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Immix Biopharma 487.25 Mn 487.25 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 912,343.00
Dec 31, 2025 933,625.00
Sep 30, 2025 965,053.00
Jun 30, 2025 972,335.00
Mar 31, 2025 991,126.00
Dec 31, 2024 1.01 Mn
Sep 30, 2024 1.03 Mn
Jun 30, 2024 1.04 Mn
Mar 31, 2024 1.06 Mn